Intraocular Lens Control Zone Redirects Peripheral Light
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Intraocular lens (IOL) implant patients often experience peripheral pseudophakic dysphotopsia (PPD), which includes negative and positive forms, causing visual disturbances, and posterior capsular opacification (PCO) leading to vision impairment, necessitating additional surgical treatments.
Innovation Solution
An intraocular lens design featuring an optic zone and a control zone that redirects peripheral light rays to retinal areas otherwise unilluminated, minimizing or eliminating PPD and controlling PCO, with specific surface profiles and configurations to manage light distribution and optical power.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If a conventional IOL design is used, then the lens structure is simple, but peripheral pseudophakic dysphotopsia (PPD) occurs causing visual disturbances
Solution Approach 1:
The IOL is divided into distinct functional zones: a central optic zone for primary vision and a peripheral control zone for managing PPD. This segmentation allows each zone to be optimized independently, with the control zone specifically designed to redirect peripheral light rays while the optic zone maintains standard optical characteristics.
Solution Approach 2:
Different regions of the IOL are assigned different optical properties. The control zone at the periphery has a specific refractive index and surface curvature designed to redirect light, while the central optic zone maintains conventional optical characteristics. This local differentiation resolves the contradiction by applying complexity only where needed.
2Reliability
If the natural crystalline lens is removed, then cataract surgery is completed, but posterior capsular opacification (PCO) develops leading to vision impairment
Solution Approach 1:
The IOL design incorporates features that proactively prevent PCO development. The control zone's specific optical properties and the lens overall design create conditions that slow or prevent lens epithelial cell proliferation, thereby maintaining capsule transparency over time without requiring additional surgical interventions.
3Illumination intensity
If peripheral light rays are not redirected, then the lens design is simple, but dark bands or missing regions appear in the peripheral visual field
Solution Approach 1:
The IOL is divided into distinct functional zones: a central optic zone for primary vision and a peripheral control zone for managing PPD. This segmentation allows each zone to be optimized independently, with the control zone specifically designed to redirect peripheral light rays while the optic zone maintains standard optical characteristics.
Solution Approach 2:
The control zone intentionally redirects peripheral light rays that would otherwise create dark bands into the peripheral retinal regions that need illumination. This converts the harmful effect of unredirected peripheral rays into a beneficial illumination effect, eliminating dark bands while requiring only moderate optical modification.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The lens effectively reduces or eliminates PPD and slows the development of PCO, enhancing visual clarity and potentially reducing the need for additional surgical interventions.
Implementation Method 1
a control zone positioned peripherally relative to the optic zone and configured to reduce, minimize, and/or eliminate negative peripheral pseudophakic dysphotopsia (PPD)... redirecting light rays from peripheral field angles onto retinal locations of the eye
Data Source
AI summary
An intraocular lens comprising: an optic zone; and a control zone positioned peripherally relative to the optic zone and configured to reduce, minimize, and/or eliminate negative peripheral pseudophakic dysphotopsia (PPD) and/or reduce, minimize, and/or eliminate posterior capsular opacification (PCO).


